+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Stem Cell Therapy Global Market Opportunities And Strategies To 2031

  • PDF Icon

    Report

  • 279 Pages
  • July 2022
  • Region: Global
  • The Business Research Company
  • ID: 5633467
This report describes and explains the global stem cell therapy market and covers 2016-2021, termed the historic period, and 2021-2026 termed the forecast period, along with further forecasts for the period 2026-2031. The report evaluates the market across each region and for the major economies within each region.

The global stem cell therapy market reached a value of nearly $4,019.6 million in 2021, having increased at a compound annual growth rate (CAGR) of 70.9% since 2016. The market is expected to grow from $4,019.6 million in 2021 to $10,600.2 million in 2026 at a rate of 21.4%. The market is then expected to grow at a CAGR of 11.4% from 2026 and reach $18,175.4 million in 2031.

Growth in the historic period in the stem cell therapy market resulted from rising prevalence of chronic diseases, a rise in funding from governments and private organizations, rapid growth in emerging markets, an increase in investments in cell and gene therapies, surge in healthcare expenditure, and an increase in pharmaceutical R&D expenditure. The market was restrained by low healthcare access in developing countries, limited reimbursements, and ethical concerns related to the use of embryonic stem cells in the research and development.

Going forward, increasing government support, rapid increase in the aging population, rising research and development spending, and increasing healthcare expenditure will drive market growth. Factors that could hinder the growth of the market in the future include high cost of stem cell therapy, stringent regulations imposed by regulators, and high cost of storage of stem cells.

The stem cell therapy market is segmented by type into allogeneic stem cell therapy and autologous stem cell therapy. The autologous stem cell therapy segment was the largest segment of the stem cell therapy market segmented by type, accounting for 100% of the total in 2021.

The stem cell therapy market is also segmented by cell source into adult stem cells, induced pluripotent stem cells, and embryonic stem cells. The induced pluripotent stem cells was the largest segment of the stem cell therapy market segmented by cell source, accounting for 77.2% of the total in 2021. Going forward, the adult stem cells segment is expected to be the fastest growing segment in the stem cell therapy market segmented by cell source, at a CAGR of 21.7% during 2021-2026.

The stem cell therapy market is also segmented by application into musculoskeletal disorders and wounds & injuries, cancer, autoimmune disorders, and others. The cancer segment was the largest segment of the stem cell therapy market segmented by application, accounting for 49.7% of the total in 2021. Going forward, musculoskeletal disorders and wounds & injuries segment is expected to be the fastest growing segment in the stem cell therapy market segmented by application, at a CAGR of 22.1% during 2021-2026.

The stem cell therapy market is also segmented by end-users into hospitals and clinics, research centers, and others. The hospitals and clinics segment was the largest segment of the stem cell therapy market segmented by end-users, accounting for 66.0% of the total in 2021. Going forward, hospitals and clinics segment is expected to be the fastest growing segment in the stem cell therapy market segmented by end-users, at a CAGR of 22.0% during 2021-2026.

North America was the largest region in the stem cell therapy market, accounting for 53.9% of the total in 2021. It was followed by the Western Europe, Asia Pacific and then the other regions. Going forward, the fastest-growing regions in the stem cell therapy market will be South America and Middle East where growth will be at CAGRs of 75.0% and 73.9% respectively during 2021-2026. These will be followed by Eastern Europe and Asia Pacific, where the markets are expected to register CAGRs of 65.6% and 43.6% respectively during 2021-2026.

The global stem cell therapy market is concentrated characterized by the presence of global stem cell therapy providers. The top ten competitors in the market made up to 24.16% of the total market in 2020. Major players in the market include Smith & Nephew plc, Fujifilm Holding Corporation, Thermo Fisher Scientific Inc., Takara Bio Inc., and MEDIPOST Co. Ltd.

The top opportunities in the stem cell therapy market segmented by type will arise in autologous stem cell therapy segment, which will gain $3,349.6 million of global annual sales by 2026. The top opportunities in the stem cell therapy market segmented by cell source will arise in induced pluripotent stem cells segment, which will gain $5,065.4 million of global annual sales by 2026. The top opportunities in the stem cell therapy market segmented by application will arise in cancer segment, which will gain $3,233.5 million of global annual sales by 2026. The top opportunities in the stem cell therapy market segmented by end-users will arise in hospitals and clinics segment, which will gain $4,502.7 million of global annual sales by 2026. The stem cell therapy market size will gain the most in the USA at $2,063.9 million.

Market-trend-based strategies for the stem cell therapy include focus on closely monitoring advances in mesenchymal stem cells therapy with a view to capitalizing on innovations in the field, market players should collaborate with, and acquire other companies to further advance product innovation and to drive revenues, companies should consider investing in developing of iPSC-derived NK cells to treat patients, companies operating in the stem cell therapy market should concentrate on developing stem cell therapy, especially for cancer to gain a competitive advantage over somatic cell competitors, and companies operating in the stem cell therapy market should make use of artificial intelligence to improve product quality, safety and manufacturing productivity.

Player-adopted strategies in the stem cell therapy market include strengthening its business by acquiring companies with same business, bringing more advancements in stem cell therapies and for the same is forming partnerships with companies having same business, focusing on new research and development and for the same is collaborating with different companies, focused on bringing more licensing deal aimed at supporting cell-based therapy R&D for diabetes, and new product development to strengthen its business.

To take advantage of the opportunities, the publisher reccomends the stem cell therapy companies to focus on strategic acquisitions and partnerships, focus on research initiatives and funding, focus on emerging markets, continue to expand in developed markets, offer value-based pricing, offer bundled payments, participate in stem cell therapy-related seminars and conferences, focus on patient referral systems and focus on collaborating with cancer treatment centers and hospitals.

Frequently Asked Questions about the Global Stem Cell Therapy Market

What is the estimated value of the Global Stem Cell Therapy Market?

The Global Stem Cell Therapy Market was estimated to be valued at $4019.6 Million in 2021.

What is the growth rate of the Global Stem Cell Therapy Market?

The growth rate of the Global Stem Cell Therapy Market is 16.3%, with an estimated value of $18175.4 Million by 2031.

What is the forecasted size of the Global Stem Cell Therapy Market?

The Global Stem Cell Therapy Market is estimated to be worth $18175.4 Million by 2031.

Who are the key companies in the Global Stem Cell Therapy Market?

Key companies in the Global Stem Cell Therapy Market include Smith & Nephew Plc, Fujifilm Holding Corporation, Thermo Fisher Scientific Inc. and MEDIPOST Co., Ltd..

Table of Contents

1. Stem Cell Therapy Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction
6.1. Segmentation by Geography
6.2. Segmentation by Type
6.3. Segmentation by Cell Source
6.4. Segmentation by Application
6.5. Segmentation by End-User

7. Stem Cell Therapy Market Characteristics
7.1. Market Definition
7.2. Segmentation by Type
7.2.1. Allogeneic Stem Cell Therapy
7.2.2. Autologous Stem Cell Therapy
7.3. Segmentation by Cell Source
7.3.1. Adult Stem Cells
7.3.2. Induced Pluripotent Stem Cells
7.3.3. Embryonic Stem Cells
7.4. Segmentation by Application
7.4.1. Musculoskeletal Disorders And Wounds & Injuries
7.4.2. Cancer
7.4.3. Autoimmune Disorders
7.4.4. Others
7.5. Segmentation by End-Users
7.5.1. Hospitals And Clinics
7.5.2. Research Centers
7.5.3. Others

8. Stem Cell Therapy Trends And Strategies
8.1. Growing Use of Mesenchymal Stem Cell Therapy
8.2. Strategic Acquisitions And Partnerships
8.3. Development Of Induced Pluripotent Stem Cell iPSC-Derived NK Cells
8.4. Demand For Stem Cell Therapy based Treatments
8.5. Use Of Artificial Intelligence

9. Impact Of Covid-19 On Stem Cell Therapy Market
9.1. Introduction
9.2. Increased Enthusiasm For Stem Cell Therapy
9.3. Increase In Research And Development Activities
9.4. Future Outlook

10. Global Stem Cell Therapy Market Size And Growth
10.1. Market Size
10.2. Historic Market Growth, 2016 - 2021, Value ($ Million)
10.2.1. Drivers Of The Market 2016 - 2021
10.2.2. Restraints On The Market 2016 - 2021
10.3. Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
10.3.1. Drivers Of The Market 2021 - 2026
10.3.2. Restraints On The Market 2021 - 2026

11. Global Stem Cell Therapy Market Segmentation
11.1. Global Stem Cell Therapy Market, Segmentation by Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.2. Global Stem Cell Therapy Market, Segmentation by Cell Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.3. Global Stem Cell Therapy Market, Segmentation by Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.4. Global Stem Cell Therapy Market, Segmentation by End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

12. Stem Cell Therapy Market, Regional And Country Analysis
12.1. Global Stem Cell Therapy Market, by Region, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.2. Global Stem Cell Therapy Market, by Country, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

13. Asia-Pacific Stem Cell Therapy Market
13.1. Asia-Pacific Stem Cell Therapy Market Overview
13.1.1. Region Information
13.1.2. Market Information
13.1.3. background Information
13.1.4. Government Initiatives
13.1.5. Regulations
13.1.6. Regulatory bodies
13.1.7. Major Associations
13.1.8. Taxes Levied
13.1.9. Corporate Tax Structure
13.1.10. Investments
13.1.11. Major Companies
13.2. Asia-Pacific Stem Cell Therapy Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.3. Asia-Pacific Stem Cell Therapy Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.4. Asia-Pacific Stem Cell Therapy Market, Segmentation by Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.5. Asia-Pacific Stem Cell Therapy Market, Segmentation by Cell Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.6. Asia-Pacific Stem Cell Therapy Market: Country Analysis
13.7. China Stem Cell Therapy Market
13.8. China Stem Cell Therapy Market Overview
13.8.1. Country Information
13.8.2. Market Information
13.8.3. background Information
13.8.4. Government Initiatives
13.8.5. Regulations
13.8.6. Regulatory bodies
13.8.7. Major Associations
13.8.8. Taxes Levied
13.8.9. Corporate Tax Structure
13.8.10. Investments
13.8.11. Major Companies
13.9. China Stem Cell Therapy Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.10. China Stem Cell Therapy Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.11. China Stem Cell Therapy Market, Segmentation by Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.12. China Stem Cell Therapy Market, Segmentation by Cell Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.13. India Stem Cell Therapy Market
13.14. India Stem Cell Therapy Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.15. India Stem Cell Therapy Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.16. India Stem Cell Therapy Market, Segmentation by Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.17. India Stem Cell Therapy Market, Segmentation by Cell Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.18. Japan Stem Cell Therapy Market
13.19. Japan Stem Cell Therapy Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.20. Japan Stem Cell Therapy Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.21. Japan Stem Cell Therapy Market, Segmentation by Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.22. Japan Stem Cell Therapy Market, Segmentation by Cell Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.23. Australia Stem Cell Therapy Market
13.24. Australia Stem Cell Therapy Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.25. Australia Stem Cell Therapy Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.26. Australia Stem Cell Therapy Market, Segmentation by Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.27. Australia Stem Cell Therapy Market, Segmentation by Cell Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.28. Indonesia Stem Cell Therapy Market
13.29. Indonesia Stem Cell Therapy Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.30. Indonesia Stem Cell Therapy Market, Segmentation by Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.31. Indonesia Stem Cell Therapy Market, Segmentation by Cell Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.32. South Korea Stem Cell Therapy Market
13.33. South Korea Stem Cell Therapy Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.34. South Korea Stem Cell Therapy Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.35. South Korea Stem Cell Therapy Market, Segmentation by Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.36. South Korea Stem Cell Therapy Market, Segmentation by Cell Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

14. Western Europe Stem Cell Therapy Market
14.1. Western Europe Stem Cell Therapy Market Overview
14.1.1. Region Information
14.1.2. Market Information
14.1.3. background Information
14.1.4. Government Initiatives
14.1.5. Regulations
14.1.6. Regulatory bodies
14.1.7. Major Associations
14.1.8. Taxes Levied
14.1.9. Corporate Tax Structure
14.1.10. Investments
14.1.11. Major Companies
14.2. Western Europe Stem Cell Therapy Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.3. Western Europe Stem Cell Therapy Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.4. Western Europe Stem Cell Therapy Market, Segmentation by Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.5. Western Europe Stem Cell Therapy Market, Segmentation by Cell Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.6. Western Europe Stem Cell Therapy Market: Country Analysis
14.7. UK Stem Cell Therapy Market
14.8. UK Stem Cell Therapy Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.9. UK Stem Cell Therapy Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.10. UK Stem Cell Therapy Market, Segmentation by Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.11. UK Stem Cell Therapy Market, Segmentation by Cell Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.12. Germany Stem Cell Therapy Market
14.13. Germany Stem Cell Therapy Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.14. Germany Stem Cell Therapy Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.15. Germany Stem Cell Therapy Market, Segmentation by Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.16. Germany Stem Cell Therapy Market, Segmentation by Cell Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.17. France Stem Cell Therapy Market
14.18. France Stem Cell Therapy Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.19. France Stem Cell Therapy Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.20. France Stem Cell Therapy Market, Segmentation by Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.21. France Stem Cell Therapy Market, Segmentation by Cell Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

15. Eastern Europe Stem Cell Therapy Market
15.1. Eastern Europe Stem Cell Therapy Market Overview
15.1.1. Region Information
15.1.2. Market Information
15.1.3. background information
15.1.4. Government Initiatives
15.1.5. Regulations
15.1.6. Regulatory bodies
15.1.7. Major Associations
15.1.8. Taxes levied
15.1.9. Corporate tax structure
15.1.10. Investments
15.1.11. Major Companies
15.2. Eastern Europe Stem Cell Therapy Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.3. Eastern Europe Stem Cell Therapy Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.4. Eastern Europe Stem Cell Therapy Market, Segmentation by Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.5. Eastern Europe Stem Cell Therapy Market, Segmentation by Cell Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.6. Eastern Europe Stem Cell Therapy Market: Country Analysis
15.7. Russia Stem Cell Therapy Market
15.8. Russia Stem Cell Therapy Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.9. Russia Stem Cell Therapy Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.10. Russia Stem Cell Therapy Market, Segmentation by Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.11. Russia Stem Cell Therapy Market, Segmentation by Cell Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

16. North America Stem Cell Therapy Market
16.1. North America stem cell therapy Market Overview
16.1.1. Region Information
16.1.2. Market Information
16.1.3. background information
16.1.4. Government Initiatives
16.1.5. Regulations
16.1.6. Regulatory bodies
16.1.7. Major Associations
16.1.8. Taxes levied
16.1.9. Corporate tax structure
16.1.10. Investments
16.1.11. Major Companies
16.2. North America Stem Cell Therapy Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.3. North America Stem Cell Therapy Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.4. North America Stem Cell Therapy Market, Segmentation by Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.5. North America Stem Cell Therapy Market, Segmentation by Cell Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.6. North America Stem Cell Therapy Market: Country Analysis
16.7. USA Stem Cell Therapy Market
16.8. USA Stem Cell Therapy Market Overview
16.8.1. Region Information
16.8.2. Market Information
16.8.3. background information
16.8.4. Government Initiatives
16.8.5. Regulations
16.8.6. Regulatory bodies
16.8.7. Major Associations
16.8.8. Taxes levied
16.8.9. Corporate tax structure
16.8.10. Investments
16.8.11. Major Companies
16.9. USA Stem Cell Therapy Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.10. USA Stem Cell Therapy Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.11. USA Stem Cell Therapy Market, Segmentation by Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.12. USA Stem Cell Therapy Market, Segmentation by Cell Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

17. South America Stem Cell Therapy Market
17.1. South America Stem Cell Therapy Market Overview
17.1.1. Region Information
17.1.2. Market Information
17.1.3. background Information
17.1.4. Government Initiatives
17.1.5. Regulations
17.1.6. Regulatory bodies
17.1.7. Major Associations
17.1.8. Taxes Levied
17.1.9. Corporate Tax Structure
17.1.10. Investments
17.1.11. Major Companies
17.2. South America Stem Cell Therapy Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
17.3. South America Stem Cell Therapy Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
17.4. South America Stem Cell Therapy Market, Segmentation by Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17.5. South America Stem Cell Therapy Market, Segmentation by Cell Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17.6. South America Stem Cell Therapy Market: Country Analysis
17.7. brazil Stem Cell Therapy Market
17.8. brazil Stem Cell Therapy Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
17.9. brazil Stem Cell Therapy Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
17.10. brazil Stem Cell Therapy Market, Segmentation by Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17.11. brazil Stem Cell Therapy Market, Segmentation by Cell Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

18. Middle East Stem Cell Therapy Market
18.1. Middle East Stem Cell Therapy Market Overview
18.1.1. Region Information
18.1.2. Market Information
18.1.3. background Information
18.1.4. Government Initiatives
18.1.5. Regulations
18.1.6. Regulatory bodies
18.1.7. Major Associations
18.1.8. Taxes levied
18.1.9. Corporate tax structure
18.1.10. Investments
18.1.11. Major Companies
18.2. Middle East Stem Cell Therapy Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
18.3. Middle East Stem Cell Therapy Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
18.4. Middle East Stem Cell Therapy Market, Segmentation by Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
18.5. Middle East Stem Cell Therapy Market, Segmentation by Cell Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

19. Africa Stem Cell Therapy Market
19.1. Africa Stem Cell Therapy Market Overview
19.1.1. Region Information
19.1.2. Market Information
19.1.3. background Information
19.1.4. Government Initiatives
19.1.5. Regulations
19.1.6. Regulatory bodies
19.1.7. Major Associations
19.1.8. Taxes Levied
19.1.9. Corporate Tax Structure
19.1.10. Investments
19.1.11. Major Companies
19.2. Africa Stem Cell Therapy Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
19.3. Africa Stem Cell Therapy Market, Segmentation by Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
19.4. Africa Stem Cell Therapy Market, Segmentation by Cell Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

20. Stem Cell Therapy Global Market Competitive Landscape
20.1. Company Profiles
20.2. Smith & Nephew plc
20.2.1. Company Overview
20.2.2. Products And Services
20.2.3. business Strategy
20.2.4. Financial Overview
20.3. Fujifilm Holding Corporation
20.3.1. Company Overview
20.3.2. Products And Services
20.3.3. business Strategy
20.3.4. Financial Overview
20.4. Thermo Fisher Scientific Inc.
20.4.1. Company Overview
20.4.2. Products And Services
20.4.3. business Strategy
20.4.4. Financial Overview
20.5. Takara bio Inc.
20.5.1. Company Overview
20.5.2. Products And Services
20.5.3. business Strategy
20.5.4. Financial Overview
20.6. MEDIPOST Co., Ltd.
20.6.1. Company Overview
20.6.2. Products And Services
20.6.3. business Strategy
20.6.4. Financial Overview

21. Stem Cell Therapy Market Pipeline Analysis

22. Key Mergers And Acquisitions In The Stem Cell Therapy Market
22.1. Catalent Acquired RheinCell Therapeutics
22.2. Sanofi Acquired Kiadis
22.3. Vertex Pharmaceuticals Acquired Semma Therapeutics
22.4. bayer Acquired blueRock Therapeutics
22.5. Evotech Acquired NCARDIA

23. Stem Cell Therapy Market Opportunities And Strategies
23.1. Global Stem Cell Therapy Market In 2026 - Countries Offering Most New Opportunities
23.2. Global Stem Cell Therapy Market In 2026 - Segments Offering Most New Opportunities
23.3. Global Stem Cell Therapy Market In 2026 - Growth Strategies
23.3.1. Market Trend based Strategies
23.3.2. Competitor Strategies

24. Stem Cell Therapy Market, Conclusions And Recommendations
24.1. Conclusions
24.2. Recommendations
24.2.1. Product
24.2.2. Place
24.2.3. Price
24.2.4. Promotion
24.2.5. People

25. Appendix
25.1. Market Data Sources
25.2. Research Methodology
25.3. Currencies
25.4. Research Inquiries
25.5. About the Publisher
26. Copyright and Disclaimer

Executive Summary

Stem Cell Therapy Global Market Opportunities And Strategies To 2031 provides the strategists; marketers and senior management with the critical information they need to assess the global stem cell therapy market as it emerges from the COVID 19 shut down.



Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Description:

Where is the largest and fastest growing market for stem cell therapy? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The stem cell therapy market global report answers all these questions and many more.


The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider stem cell therapy market; and compares it with other markets.



The report covers the following chapters:

  • Executive Summary - The executive summary section of the report gives a brief overview and summary of the report.
  • Report Structure - This section gives the structure of the report and the information covered in the various sections.
  • Introduction - The introduction section of the report gives brief introduction about segmentation by geography, by type, by cell source, by end-user, and by application.
  • Market Characteristics - The market characteristics section of the report defines and explains the stem cell therapy market. This section also defines and describes goods and related services covered in the report.
  • Trends And Strategies - This section describes the major trends shaping the global stem cell therapy market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • Impact of COVID-19 - This section describes the impact of COVID-19 on the stem cell therapy market.
  • Global Market Size And Growth - This section contains the global historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis - This section contains the historic (2016-2021) and forecast (2021-2026, and 2026-2031) market values and growth and market share comparison by region.
  • Segmentation - This section contains the market values (2016-2031) and analysis for different segments.
  • Regional Market Size and Growth - This section contains the region’s market size (2021), historic (2016-2021) and forecast (2021-2026, and 2026-2031) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
  • Competitive Landscape - This section covers details on the competitive landscape of the global stem cell therapy market, estimated market shares and company profiles for the leading players.
  • Key Mergers And Acquisitions - This section gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies - This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions And Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for stem cell therapy providers in terms of product/service offerings, geographic expansion, marketing strategies and target groups.
  • Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope:


Markets Covered:


  1. 1) By Type: Allogeneic Stem Cell Therapy; Autologous Stem Cell Therapy
  2. 2) By Cell Source: Adult Stem Cells; Induced Pluripotent Stem Cells; Embryonic Stem Cells
  3. 3) By Application: Musculoskeletal Disorders and Wounds & Injuries; Cancer; Autoimmune Disorders; Others
  4. 4) By End-Users: Hospitals And Clinics; Research Centers; Others

Companies Mentioned:

Smith & Nephew Plc; Fujifilm Holding Corporation; Thermo Fisher Scientific Inc.; Takara Bio Inc; MEDIPOST Co., Ltd.


Countries:

China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia


Regions:

Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa


Time series:

Five years historic and ten years forecast.


Data:

Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; stem cell therapy indicators comparison.


Data segmentations:

country and regional historic and forecast data; market share of competitors; market segments.


Sourcing and Referencing:

Data and analysis throughout the report is sourced using end notes.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Smith & Nephew Plc
  • Fujifilm Holding Corporation
  • Thermo Fisher Scientific Inc.
  • Takara Bio Inc.
  • MEDIPOST Co., Ltd.

Methodology

Loading
LOADING...